|
Immunonutrition in ERAS Protocols in Gynecologic Oncology
RECRUITINGN/ASponsored by National and Kapodistrian University of Athens
Actively Recruiting
PhaseN/A
SponsorNational and Kapodistrian University of Athens
Started2023-10-18
Est. completion2025-05-30
Eligibility
Age20 Years – 80 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06103526
Summary
A patient with oncological pathology of any type because of impaired digestion and nutrient absorption, decreased intake, and increased nutrition requirements has an increased risk of malnutrition and moderate to severe weight loss.In the present study the investigators will evaluate the impact of perioperative immunonutrition supplementation on the postoperative outcomes.
Eligibility
Age: 20 Years – 80 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * women with any gynaecologic malignancy enrolled in surgical list of our institute * must be able to consume oral supplements. Exclusion Criteria: * women that are not able to follow ERAS protocol due to medical reasons * patients with severe disease that cannot compromise with protocol
Conditions4
CancerERASGynecologic CancerNutritional Deficiency
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorNational and Kapodistrian University of Athens
Started2023-10-18
Est. completion2025-05-30
Eligibility
Age20 Years – 80 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06103526